Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2019-09-03Economic evaluation of sunitinib versus pazopanib and best supportive care for the treatment of metastatic renal cell carcinoma in Chile: cost-effectiveness analysis and a mixed treatment comparisonVargas, C; Balmaceda, C; Rodríguez, F; Rojas, R; Giglio, A; Espinoza, MA
2007-01Clinical activity of overseas-trained doctors practising in general practice in AustraliaBayram, C; Knox, SA; Ng, A; Britt, H
2020-12The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?Whitehurst, DGT; Brazier, JE; Viney, R; Mulhern, BJ
2015-11-26Comparing the measurement equivalence of EQ-5D-5L across different modes of administrationMulhern, B; O'Gorman, H; Rotherham, N; Brazier, J
2002-12-01Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergiesBridges, JFP; Stewart, M; King, MT; Van Gool, K
2009-11-10Choice experiments in health: The good, the bad, the ugly and toward a brighter futureLouviere, JJ; Lancsar, E
2016-01-01An empirical study of two alternative comparators for use in time trade-off studiesShah, K; Mulhern, B; Longworth, L; Janssen, MF
2008-04-01Horizontal inequities in Australia's mixed public/private health care systemVan Doorslaer, E; Clarke, P; Savage, E; Hall, J
2014-01-01Preparatory study for the revaluation of the EQ-5D tariff: Methodology reportMulhern, B; Bansback, N; Brazier, J; Buckingham, K; Cairns, J; Devlin, N; Dolan, P; Hole, AR; Kavetsos, G; Longworth, L; Rowen, D; Tsuchiya, A
2008-04-04The use of QALY weights for QALY calculations: A review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4Scuffham, PA; Whitty, JA; Mitchell, A; Viney, R
Results 211-220 of 261 (Search time: 0.031 seconds).